FDA Approves First Treatment for Ebola Virus
Submitted by [email protected] on Wed, 10/14/2020 - 12:00 PM
On October 14, 2020 the U.S. Food and Drug Administration (FDA) approved Inmazeb an antibody mixture consisting of atoltivimab, maftivimab, and odesivimab-ebgn. This is the FDA's first approved treatment for the Ebola virus.
Content Source: Press Release
Content Author: US Food and Drug Administration